Cargando…

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

It is classically recognized that the physiological and oncogenic functions of Myc proteins depend on specific DNA binding enabled by the dimerization of its C-terminal basic-region-Helix-Loop-Helix-Leucine Zipper (b-HLH-LZ) domain with that of Max. However, a new paradigm is emerging, where the bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltais, Loïka, Montagne, Martin, Bédard, Mikaël, Tremblay, Cynthia, Soucek, Laura, Lavigne, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370111/
https://www.ncbi.nlm.nih.gov/pubmed/28350847
http://dx.doi.org/10.1371/journal.pone.0174413
_version_ 1782518183485243392
author Maltais, Loïka
Montagne, Martin
Bédard, Mikaël
Tremblay, Cynthia
Soucek, Laura
Lavigne, Pierre
author_facet Maltais, Loïka
Montagne, Martin
Bédard, Mikaël
Tremblay, Cynthia
Soucek, Laura
Lavigne, Pierre
author_sort Maltais, Loïka
collection PubMed
description It is classically recognized that the physiological and oncogenic functions of Myc proteins depend on specific DNA binding enabled by the dimerization of its C-terminal basic-region-Helix-Loop-Helix-Leucine Zipper (b-HLH-LZ) domain with that of Max. However, a new paradigm is emerging, where the binding of the c-Myc/Max heterodimer to non-specific sequences in enhancers and promoters drives the transcription of genes involved in diverse oncogenic programs. Importantly, Max can form a stable homodimer even in the presence of c-Myc and bind DNA (specific and non-specific) with comparable affinity to the c-Myc/Max heterodimer. Intriguingly, alterations in the Max gene by germline and somatic mutations or changes in the gene product by alternative splicing (e.g. ΔMax) were recently associated with pheochromocytoma and glioblastoma, respectively. This has led to the proposition that Max is, by itself, a tumor suppressor. However, the actual mechanism through which it exerts such an activity remains to be elucidated. Here, we show that contrary to the WT motif, the b-HLH-LZ of ΔMax does not homodimerize in the absence of DNA. In addition, although ΔMax can still bind the E-box sequence as a homodimer, it cannot bind non-specific DNA in that form, while it can heterodimerize with c-Myc and bind E-box and non-specific DNA as a heterodimer with high affinity. Taken together, our results suggest that the WT Max homodimer is important for attenuating the binding of c-Myc to specific and non-specific DNA, whereas ΔMax is unable to do so. Conversely, the splicing of Max into ΔMax could provoke an increase in overall chromatin bound c-Myc. According to the new emerging paradigm, the splicing event and the stark reduction in homodimer stability and DNA binding should promote tumorigenesis impairing the tumor suppressor activity of the WT homodimer of Max.
format Online
Article
Text
id pubmed-5370111
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53701112017-04-06 Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers Maltais, Loïka Montagne, Martin Bédard, Mikaël Tremblay, Cynthia Soucek, Laura Lavigne, Pierre PLoS One Research Article It is classically recognized that the physiological and oncogenic functions of Myc proteins depend on specific DNA binding enabled by the dimerization of its C-terminal basic-region-Helix-Loop-Helix-Leucine Zipper (b-HLH-LZ) domain with that of Max. However, a new paradigm is emerging, where the binding of the c-Myc/Max heterodimer to non-specific sequences in enhancers and promoters drives the transcription of genes involved in diverse oncogenic programs. Importantly, Max can form a stable homodimer even in the presence of c-Myc and bind DNA (specific and non-specific) with comparable affinity to the c-Myc/Max heterodimer. Intriguingly, alterations in the Max gene by germline and somatic mutations or changes in the gene product by alternative splicing (e.g. ΔMax) were recently associated with pheochromocytoma and glioblastoma, respectively. This has led to the proposition that Max is, by itself, a tumor suppressor. However, the actual mechanism through which it exerts such an activity remains to be elucidated. Here, we show that contrary to the WT motif, the b-HLH-LZ of ΔMax does not homodimerize in the absence of DNA. In addition, although ΔMax can still bind the E-box sequence as a homodimer, it cannot bind non-specific DNA in that form, while it can heterodimerize with c-Myc and bind E-box and non-specific DNA as a heterodimer with high affinity. Taken together, our results suggest that the WT Max homodimer is important for attenuating the binding of c-Myc to specific and non-specific DNA, whereas ΔMax is unable to do so. Conversely, the splicing of Max into ΔMax could provoke an increase in overall chromatin bound c-Myc. According to the new emerging paradigm, the splicing event and the stark reduction in homodimer stability and DNA binding should promote tumorigenesis impairing the tumor suppressor activity of the WT homodimer of Max. Public Library of Science 2017-03-28 /pmc/articles/PMC5370111/ /pubmed/28350847 http://dx.doi.org/10.1371/journal.pone.0174413 Text en © 2017 Maltais et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Maltais, Loïka
Montagne, Martin
Bédard, Mikaël
Tremblay, Cynthia
Soucek, Laura
Lavigne, Pierre
Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title_full Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title_fullStr Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title_full_unstemmed Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title_short Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers
title_sort biophysical characterization of the b-hlh-lz of δmax, an alternatively spliced isoform of max found in tumor cells: towards the validation of a tumor suppressor role for the max homodimers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370111/
https://www.ncbi.nlm.nih.gov/pubmed/28350847
http://dx.doi.org/10.1371/journal.pone.0174413
work_keys_str_mv AT maltaisloika biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers
AT montagnemartin biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers
AT bedardmikael biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers
AT tremblaycynthia biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers
AT souceklaura biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers
AT lavignepierre biophysicalcharacterizationofthebhlhlzofdmaxanalternativelysplicedisoformofmaxfoundintumorcellstowardsthevalidationofatumorsuppressorroleforthemaxhomodimers